Clinical Necessity Guidelines for Psychotherapy, Insurance Medical Necessity and Utilization Review Protocols, and Mental Health Parity

被引:8
作者
Lazar, Susan G. [1 ,2 ,3 ]
Bendat, Meiram [4 ,5 ]
Gabbard, Glen [6 ,7 ]
Levy, Kenneth [8 ,9 ]
McWilliams, Nancy [10 ,11 ]
Plakun, Eric M. [12 ,13 ]
Shedler, Jonathan [14 ]
Yeomans, Frank [8 ,9 ]
机构
[1] George Washington Univ, Sch Med, Dept Psychiat, Washington, DC USA
[2] Washington Psychoanalyt Inst, Washington, DC USA
[3] Uniformed Serv Univ Hlth Sci, Dept Psychiat, Bethesda, MD 20814 USA
[4] Psych Appeal Inc, Los Angeles, CA USA
[5] New Ctr Psychoanal, Los Angeles, CA USA
[6] Baylor Coll Med, Dept Psychiat, Houston, TX 77030 USA
[7] Ctr Psychoanalyt Studies Houston, Houston, TX USA
[8] Penn State Univ, Dept Psychol, University Pk, PA 16802 USA
[9] Cornell Univ, Dept Psychiat, Weill Med Coll, New York, NY 10021 USA
[10] Rutgers State Univ, Grad Sch Appl & Profess Psychol, Piscataway, NJ USA
[11] Ctr Psychotherapy & Psychoanal New Jersey, Madison, NJ USA
[12] Austen Riggs Ctr Inc, Biopsychosocial Advocacy, Stockbridge, MA USA
[13] Amer Psychiat Assoc, Psychotherapy Caucus, Washington, DC USA
[14] Univ Colorado, Sch Med, Dept Psychiat, Aurora, CO USA
关键词
psychotherapy; parity; Mental Health Parity and Addiction Equity Act (MHPAEA); Coalition for Psychotherapy Parity; utilization review; insurance; medical necessity; BORDERLINE PERSONALITY-DISORDER; COMORBIDITY SURVEY REPLICATION; TERM PSYCHODYNAMIC PSYCHOTHERAPY; COGNITIVE-BEHAVIORAL THERAPY; MAJOR DEPRESSIVE DISORDER; TRANSFERENCE-FOCUSED PSYCHOTHERAPY; DSM-IV DISORDERS; 3-YEAR FOLLOW-UP; LONG-TERM; UTILIZATION MANAGEMENT;
D O I
10.1097/PRA.0000000000000309
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
The founding members of the Coalition for Psychotherapy Parity present Clinical Necessity Guidelines for Psychotherapy, Insurance Medical Necessity and Utilization Review Protocols, and Mental Health Parity. These guidelines support access to psychotherapy as prescribed by the clinician without arbitrary limitations on duration or frequency. The authors of the guidelines first review the evidence that psychotherapy is effective, cost-effective, and often provides a cost-offset in decreased overall medical expenses, morbidity, mortality, and disability. They highlight the disparity between clinicians' knowledge of generally accepted standards of care for mental health and substance use disorders and the much more limited crisis stabilization focus of many insurance companies. The clinical trials that health insurers cite as justification for authorizing only brief treatment for all patients involve highly selected, atypical populations that are not representative of the general population of patients in need of mental health care, who typically have complex conditions and chronic, recurring symptoms requiring ongoing availability of treatment. The standard for other medical conditions reimbursed by insurance is continuation of effective treatment until meaningful recovery, which is therefore the standard required by the Mental Health Parity and Addiction Equity Act for mental health care. However, insurance companies frequently evade the legal requirement to cover treatment of mental illness at parity with other medical conditions. They do this by applying inaccurate proprietary definitions of medical necessity and imposing utilization review procedures much more restrictively for mental health treatment than for other medical care to block access to ongoing care, thus containing insurance company costs in the short term without consideration of the adverse sequelae of undertreated illness (eg, increased costs of other medical services and increased morbidity, mortality, and costs to society in increased disability). The authors of the guidelines conclude that, given appropriate medical necessity guidelines at parity with other medical care, consistent with provider expertise and a broad range of psychotherapy research, there would be no need or place for utilization review protocols. Individuals and psychotherapy organizations are invited to visit the website psychotherapyparity.org to sign on to the guidelines to indicate agreement and support.
引用
收藏
页码:179 / 193
页数:15
相关论文
共 107 条
  • [1] American Medical Association Statement to the Institute of Medicine's Committee on Determination of Essential Health Benefits, 2011, AM MED ASS STAT I ME
  • [2] American Psychiatric Association (APA) Official Actions Position Statement on Medical Necessity Definition, 2015, OFF ACT POS STAT MED
  • [3] American Society of Addiction Medicine (ASAM), 2009, PUBL POL STAT MAN CA
  • [4] [Anonymous], 2020, HEP DIS BURD
  • [5] [Anonymous], 1990, MEDICARE STRATEGY QU
  • [6] [Anonymous], 2006, PSYCHODYNAMIC DIAGNO
  • [7] [Anonymous], 1980, DIAGN STAT MAN MENT
  • [8] [Anonymous], 2009, Borderline personality disorder: Treatment and management
  • [9] The Origins of Neuroticism
    Barlow, David H.
    Ellard, Kristen K.
    Sauer-Zavala, Shannon
    Bullis, Jacqueline R.
    Carl, Jenna R.
    [J]. PERSPECTIVES ON PSYCHOLOGICAL SCIENCE, 2014, 9 (05) : 481 - 496
  • [10] Health service utilization costs for borderline personality disorder patients treated with psychoanalytically oriented partial hospitalization versus general psychiatric care
    Bateman, A
    Fonagy, P
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 2003, 160 (01) : 169 - 171